Get started
MMM

MINDBIO THERAPEUTICS CORP.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

MBIO chart


Full chart

Key stats


Market capitalization
‪3.99 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.005 CAD
Net income (FY)
‪−376.64 K‬ CAD
Revenue (FY)
0.00 CAD
Shares float
‪125.81 M‬
Beta (1Y)
−0.49

About MINDBIO THERAPEUTICS CORP.


Sector
Health Technology
CEO
Justin Adam Hanka
Headquarters
Melbourne
Website
mindbiotherapeutics.com
Founded
2020
FIGI
BBG01GJY7SB7
Mindbio Therapeutics Corp. engages in developing psychedelic medicines to treat medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. The company was founded by Gavin Upiter and Justin Hanka in 2020 and is headquartered in Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MBIO news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MBIO is 0.030 CAD — it hasn't changed in the past 24 hours. Watch MINDBIO THERAPEUTICS CORP. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange MINDBIO THERAPEUTICS CORP. stocks are traded under the ticker MBIO.
MBIO stock has fallen by −14.29% compared to the previous week, the month change is a 20.00% rise, over the last year MINDBIO THERAPEUTICS CORP. has showed a 50.00% increase.
MBIO reached its all-time high on May 9, 2023 with the price of 0.560 CAD, and its all-time low was 0.015 CAD and was reached on Jan 22, 2024. View more price dynamics on MBIO chart.
See other stocks reaching their highest and lowest prices.
MBIO stock is 20.00% volatile and has beta coefficient of −0.49. Track MINDBIO THERAPEUTICS CORP. stock price on the chart and check out the list of the most volatile stocks — is MINDBIO THERAPEUTICS CORP. there?
Yes, you can track MINDBIO THERAPEUTICS CORP. financials in yearly and quarterly reports right on TradingView.
MBIO net income for the last quarter is ‪−236.19 K‬ CAD, while the quarter before that showed ‪58.52 K‬ CAD of net income which accounts for −503.57% change. Track more MINDBIO THERAPEUTICS CORP. financial stats to get the full picture.
No, MBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MINDBIO THERAPEUTICS CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MINDBIO THERAPEUTICS CORP. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MINDBIO THERAPEUTICS CORP. stock shows the sell signal. See more of MINDBIO THERAPEUTICS CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.